CN101595124A - 使用铜氧还蛋白预防癌症的组合物及方法 - Google Patents

使用铜氧还蛋白预防癌症的组合物及方法 Download PDF

Info

Publication number
CN101595124A
CN101595124A CNA2007800417624A CN200780041762A CN101595124A CN 101595124 A CN101595124 A CN 101595124A CN A2007800417624 A CNA2007800417624 A CN A2007800417624A CN 200780041762 A CN200780041762 A CN 200780041762A CN 101595124 A CN101595124 A CN 101595124A
Authority
CN
China
Prior art keywords
cupredoxin
peptide
azurin
cancer
pseudomonas aeruginosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800417624A
Other languages
English (en)
Chinese (zh)
Inventor
T·达什古普塔
A·查克拉博蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois System filed Critical University of Illinois System
Publication of CN101595124A publication Critical patent/CN101595124A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CNA2007800417624A 2006-09-14 2007-09-13 使用铜氧还蛋白预防癌症的组合物及方法 Pending CN101595124A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
US60/844,358 2006-09-14

Publications (1)

Publication Number Publication Date
CN101595124A true CN101595124A (zh) 2009-12-02

Family

ID=39184582

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800417624A Pending CN101595124A (zh) 2006-09-14 2007-09-13 使用铜氧还蛋白预防癌症的组合物及方法

Country Status (13)

Country Link
EP (1) EP2061498A4 (enExample)
JP (2) JP2010503409A (enExample)
KR (1) KR20090059152A (enExample)
CN (1) CN101595124A (enExample)
AU (1) AU2007296429A1 (enExample)
BR (1) BRPI0714987A2 (enExample)
CA (1) CA2663498A1 (enExample)
IL (1) IL197602A0 (enExample)
MX (1) MX2009002787A (enExample)
NO (1) NO20091267L (enExample)
RU (1) RU2009113812A (enExample)
SG (1) SG174784A1 (enExample)
WO (1) WO2008033987A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
KR20070108128A (ko) 2004-10-07 2007-11-08 아난다 차크라바르티 쿠프레독신 유래된 수송제 및 이들의 이용 방법
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
BRPI0615562A2 (pt) 2005-07-19 2010-01-26 Univ Illinois agentes de transporte para atravessamento da barreira sangue-cérebro e entrada nas células cancerìgenas do cérebro e métodos para o seu uso
WO2008070672A2 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and cpg rich dna
CA2677803A1 (en) 2007-02-08 2008-08-14 The Board Of Trustees Of The University Of Illinois Compositions and methods to prevent cancer with cupredoxins
AU2017433280B2 (en) * 2017-09-29 2025-03-06 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
KR20070108128A (ko) * 2004-10-07 2007-11-08 아난다 차크라바르티 쿠프레독신 유래된 수송제 및 이들의 이용 방법
JP2008539795A (ja) * 2005-05-20 2008-11-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ キュプレドキシンを用いたエフリン信号伝達に関する症状を治療するための組成物および方法
AU2006284490A1 (en) * 2005-07-19 2007-03-01 The Board Of Trustees Of The University Of Illinois Compositions and methods to control angiogenesis with cupredoxins

Also Published As

Publication number Publication date
WO2008033987A2 (en) 2008-03-20
EP2061498A2 (en) 2009-05-27
RU2009113812A (ru) 2010-10-20
JP2010503409A (ja) 2010-02-04
JP2014050390A (ja) 2014-03-20
AU2007296429A1 (en) 2008-03-20
BRPI0714987A2 (pt) 2013-07-30
CA2663498A1 (en) 2008-03-20
WO2008033987A3 (en) 2009-04-30
SG174784A1 (en) 2011-10-28
IL197602A0 (en) 2011-08-01
EP2061498A4 (en) 2009-11-04
NO20091267L (no) 2009-06-04
KR20090059152A (ko) 2009-06-10
MX2009002787A (es) 2009-08-27

Similar Documents

Publication Publication Date Title
CN101595124A (zh) 使用铜氧还蛋白预防癌症的组合物及方法
US10117905B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10086037B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10351605B2 (en) Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways
CN101600447A (zh) 铜氧还蛋白衍生肽类的修饰物及其使用方法
US8158574B2 (en) Compositions and methods to prevent cancer with cupredoxins
KR20080019615A (ko) 쿠프레독신과 시토크롬으로 말라리아를 치료하기 위한조성물과 방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20091202